Diabetic Retinopathy Tethered Augmented Reality With Eye4 Study

Completed · Not applicable · Has a placebo group

Conditions studied: Diabetic Retinopathy, Low Vision

In brief

Diabetes has reached epidemic levels in North America and with it, diabetic retinopathy is increasingly affecting the vision of millions of people. Despite treatment many patients still have vision loss that cannot be improved medically or with prescription eyeglasses. Our study is going to look at an FDA Class 1 Exempted visual aid that uses augmented reality to help people see better.

Key facts

Study ID

NCT05491746

Run by

Eyedaptic

People needed

20

Starts

2022-07-01

Expected to finish

2022-10-01

Last updated by the study team

2023-02-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Best correct visual acuity in the better seeing eye between 20/60 and 20/800
• History of diabetic retinopathy

You may not qualify if…

• Unable to complete the visit
• Unable to give a reliable measurement of vision
• Unable to comfortably wear the glasses for at least 60 minutes

Where it is running

• Eyedaptic — Laguna Hills, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.